ACTIV-3 is an NIH-led public-private partnership designed to accelerate the development of the most promising treatments and vaccine candidates for COVID-19.... Dec 18
BENLYSTA is the first medicine approved to treat systemic lupus and adults with active lupus nephritis, an important treatment advance for patients with this incurable ... Dec 18
-Advertisements-